theory clinical_71_1
imports Main

begin

typedecl entity
typedecl event

consts
  Conversion :: "entity ⇒ bool"
  PIP2 :: "entity ⇒ bool"
  PIP3 :: "entity ⇒ bool"
  PI3K :: "entity ⇒ bool"
  PlasmaMembrane :: "entity ⇒ bool"
  PDK1 :: "entity ⇒ bool"
  AKT :: "entity ⇒ bool"
  Provide :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Recruitment :: "event ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  To :: "event ⇒ entity ⇒ bool"
  At :: "event ⇒ entity ⇒ bool"
  DockingSite :: "entity ⇒ bool"
  For :: "event ⇒ entity ⇒ bool"
  PKB_Akt :: "entity ⇒ bool"
  Bind :: "event ⇒ bool"
  Allow :: "event ⇒ bool"
  Access :: "event ⇒ bool"
  Phosphorylate :: "event ⇒ bool"
  In :: "entity ⇒ string ⇒ bool"
  LeadTo :: "event ⇒ entity ⇒ bool"
  Partial :: "entity ⇒ bool"
  Activation :: "entity ⇒ bool"
  On :: "entity ⇒ entity ⇒ bool"

(* Explanation 1: The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT. *)
axiomatization where
  explanation_1: "∃x y z w v u t e1 e2 e3 e4. Conversion x ∧ PIP2 y ∧ PIP3 z ∧ PI3K w ∧ PlasmaMembrane v ∧ PDK1 u ∧ AKT t ∧ Provide e1 ∧ Agent e1 x ∧ Recruitment e2 ∧ Agent e2 w ∧ To e2 w ∧ At e2 v ∧ DockingSite e3 ∧ Patient e1 e3 ∧ For e4 u ∧ For e4 t"

(* Explanation 2: PKB/Akt binds to PIP3 at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the “activation loop,” leading to partial PKB/Akt activation. *)
axiomatization where
  explanation_2: "(∃x y z u v w e1 e2 e3 e4. PKB_Akt x ∧ PIP3 y ∧ PlasmaMembrane z ∧ PDK1 u ∧ T308 v ∧ Activation w ∧ Bind e1 ∧ Agent e1 x ∧ Patient e1 y ∧ At y z ∧ Allow e2 ∧ Agent e2 x ∧ Access e3 ∧ Agent e3 u ∧ Phosphorylate e4 ∧ Agent e4 u ∧ Patient e4 v ∧ In v 'activation loop' ∧ LeadTo e1 w ∧ Partial w)"

theorem hypothesis:
  assumes asm: "PKB_Akt x ∧ DockingSite y ∧ PI3K z ∧ PlasmaMembrane w"
  (* Hypothesis: PKB/Akt binds to the docking site on PI3K at the plasma membrane leading to a partial PKB/Akt activation. *)
  shows "∃x y z e1 e2. PKB_Akt x ∧ DockingSite y ∧ PI3K z ∧ PlasmaMembrane w ∧ Bind e1 ∧ Agent e1 x ∧ Patient e1 y ∧ On y z ∧ At y w ∧ Activation e2 ∧ Partial e2 ∧ LeadTo e1 e2"
proof -
  (* From the premise, we have known information about PKB_Akt, DockingSite, PI3K, and PlasmaMembrane. *)
  from asm have "PKB_Akt x ∧ DockingSite y ∧ PI3K z ∧ PlasmaMembrane w" <ATP>
  (* Explanation 1 provides that the conversion of PIP2 to PIP3 provides a docking site for PDK1 and AKT. *)
  (* Explanation 2 states that PKB/Akt binds to PIP3 at the plasma membrane, leading to partial PKB/Akt activation. *)
  (* We need to show that PKB/Akt binds to the docking site on PI3K at the plasma membrane, leading to partial activation. *)
  (* From the logical relation Implies(D, F), we know that if PKB/Akt binds to PIP3 at the plasma membrane, it leads to partial activation. *)
  (* Since we have PKB_Akt x and DockingSite y, we can infer that PKB/Akt binds to the docking site on PI3K. *)
  have "Bind e1 ∧ Agent e1 x ∧ Patient e1 y ∧ On y z ∧ At y w" <ATP>
  (* From the derived implication Implies(D, F), we can conclude that this binding leads to partial activation. *)
  then have "Activation e2 ∧ Partial e2 ∧ LeadTo e1 e2" <ATP>
  then show ?thesis <ATP>
qed

end
